Evidence map›Paper›PMID 33163174›Full record

ArticleAnnals of medicine and surgery (2012)2020

Quality of life among patients on levothyroxine: A cross-sectional study.

Thekraiat Al Quran, Ziad Bataineh, Abdel-Hameed Al-Mistarehi, Abdulhakeem Okour, Othman Beni Yonis, Adi Khassawneh, Rana AbuAwwad, Anood Al Qura'an

Abstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thekraiat Al QuranDepartment of Public Health and Family medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Ziad BatainehDepartment of General Surgery, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Abdel-Hameed Al-MistarehiDepartment of Public Health and Family medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Abdulhakeem OkourDepartment of Public Health and Family medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Othman Beni YonisDepartment of Public Health and Family medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Adi KhassawnehDepartment of Public Health and Family medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Rana AbuAwwadDepartment of Public Health and Family medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Anood Al Qura'anDepartment of Internal Medicine, Jordanian Royal Medical Services, Amman, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThyroid disorders affect the life quality of patients in various aspects. The present work aims at investigating the effect of thyroid hormonal status on the quality of life (QoL) among patients receiving Levothyroxine at the level of primary healthcare.

methodsAll patients receiving Levothyroxine at an academic primary healthcare center were included in a cross-sectional evaluation. QoL was measured by the Thyroid-Related Patient-Reported Outcome questionnaire (ThyPRO). The conducted analysis was based on the last thyroid hormones level during the last year and questionnaire scores where higher scores indicated lower QoL.

resultsWe included 127 patients; all domains of their QoL questionnaire were affected. The highest scored domain of the ThyPRO was tiredness, while the least was goiter symptoms. An association between the affected QoL and thyroid hormones could not be built. Certain domains of the ThyPRO were influenced by the existence of comorbid diseases.

conclusionsQoL was impacted in patients receiving Levothyroxine, regardless of hormonal status. Management of comorbid diseases and patients' concerns are advised to be taken into consideration to achieve a satisfying treatment. We highly recommend the integration of health life quality assessments in primary health care systems.

Indexed as

LevothyroxinePrimary careQuality of lifeThyroid diseaseThyroid-stimulating hormone

Identifiers

PMID33163174
PMCPMC7607046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.